Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy.

Varin J, Morival C, Maillard N, Adjali O, Cronin T.

DOI: 10.3390/ijms222312818
Published: 2021-11-26
Container: Int J Mol Sci
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ijms222312818,
  title = {Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy.},
  author = {Varin J and  Morival C and  Maillard N and  Adjali O and  Cronin T.},
  year = {2021},
  journal = {Int J Mol Sci},
  doi = {10.3390/ijms222312818},
  url = {https://doi.org/10.3390/ijms222312818}
}

RIS

TY  - JOUR
TI  - Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy.
AU  - Varin J
AU  -  Morival C
AU  -  Maillard N
AU  -  Adjali O
AU  -  Cronin T.
PY  - 2021
JO  - Int J Mol Sci
DO  - 10.3390/ijms222312818
UR  - https://doi.org/10.3390/ijms222312818
ER  -

APA

J, V., C, M., N, M., O, A., & T., C. (2021). Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy.. Int J Mol Sci. https://doi.org/10.3390/ijms222312818

Source records

europe-pmc · retrieved 2026-09-27T14:00:25.159Z